Professor Dr. Thomas Efferth
Education:
1980-1986 Study of Biology, Technical University Darmstadt, Germany
1990 PhD Thesis, German Cancer Research Center, Heidelberg, Germany
1997 Habilitation (Postdoctorate Thesis), Tech. Univ.Aachen, Germany
Positions:
2005 Research group leader, German Cancer Res. Center, Heidelberg
2007 Associate Professor (apl.), University of Heidelberg, Germany
2009 Full Professor, Chair of the Department of Pharmaceutical Biology,
Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University,
Mainz, Germany
2021 Director, Institute of Pharmaceutical and Biomedical Sciences,
Johannes Gutenberg University, Mainz, Germany
Honors:
1991 Ludolf Krehl-Award (1st place), Southwest-German Soc.for Medicine
2006 Honorary professor, Northeast Forestry University, Harbin, China
2006 Dr. Wilmar Schwabe Award, Society for Medical Plant Research in Helsinki, Finland,
August 30th 2006
2008 Citizen Medal (Bürgerplakette) of the City of Heidelberg, Germany
2010 Visiting professor, Zhejiang Medical University, Hangzhou, China
2011 Award (1st place) of the Central European Society for Anticancer Drug
Research (CESAR) for translational research in the development of antitumoral agents
2015 Honorary professor, Zhejiang Medical University, Hangzhou, China
2015 Visiting professor, Zhejiang Univ. Sci. Technol., Hangzhou, China
2015 “TheSCENTEDdrop” Award (1st place) for research on medicinal herbs and fragrant plants,
Graz, Austria
2016 Appreciation Award, Salah Wanasi Foundation for Cancer Research and Control,
Khartoum, Sudan
2017 Qihuang International Award, Chinese Society of Chinese Medicine
2018 Honorary adjunct professor, Chinese University of Hong Kong
2018 Full member, World Academy of Sciences (WAS)
2019 Honorary professor, Hong Kong Baptist University
2020 Top 2% in the Stanford University worldwide citation ranking 2019
of all scientists and scientific disciplines (Ioannidis et al., PLoS Biol 2020;18:e3000918;
https://data.mendeley.com/datasets/btchxktzyw/2)
2021 High Impact Paper Award of the journal “Engineering”
(edited by Chinese Academy of Engineering) for the fifth-most cited paper in 2019 (top 3.5%)
Achievements:
- 700 PubMed-listed publications
- Hirsch factor (h-index): 88 (according to Google Scholar)
- Total number of citations: 41,000 (according to Google Scholar)
- 43 book chapters, four books
- 300 lectures at international conferences
- 200 posters at international conferences
- 8 patents
Editorial Boards:
- Editor-in-Chief: Phytomedicine (since 2017); Phytomedicine Plus (since 2020), Medicinal and Aromatic Plants (2014-2018); Phytopharmacology (2011-2013)
- Co-Editor: Pharmaceuticals (since 2020), Naunyn-Schmiedeberg’s Archives of Pharmacology (since 2018), Journal of Ethnopharmacology (since 2017); Eur. J. Med. Plants (2014-2018), Phytomedicine (2014-2016), Frontiers in Pharmacology (since 2010), Planta Medica (2007-2015) etc.
- Editorial Board member: Cancer Lett., Int. J. Oncol., Curr. Med. Chem., Crit. Rev. Oncogen., Chem-Biol. Interact., Cancer Genomics Proteomics, World J. Translat. Med., World J. Pharmacol., Cancer Drug Resistance, Onco Therapeutics etc.
Society Memberships:
- Vice-president, Specialty Committee on Immunology of TCM, World Federation of Chinese Medicine Societies
- Scientific advisory member, German Pharmaceutical Society (DPhG)
- Executive council member, Natural Product Section, International Union of Basic and Clinical Pharmacology (IUPHAR)
- Board of directors, German-Chinese Research foundation for Traditional Chinese Medicine
- Board of directors, Good Practice in TCM Research Association
- Member, Society for Medicinal Plant Research (GA)
- Member, International Society of Ethnopharmacology
Scientific Advisory Board Memberships:
- Research Grant Council Hong Kong (since 2016)
- Herbal Medicinal Products Platform Austria (HMPPA) (since 2016)
- Institute of Biotechnology and Drug Research, Johannes Gutenberg University Mainz, Germany (since 2015)
- Agricultural Biotechnology Research Center, Academia Sinica, Taipei Taiwan (since 2013)
- Competence Network Complementary Medicine in Oncology (KOKON). Hospital Nuremberg (2012-2020)
- HanseMerkur Zentrum, Universitätsklinikum Eppendorf, Hamburg (since 2010)
- International Institute of Anticancer Research, Athens, Greece (since 2009)
- Begell House Publishers, New York, USA (2012-2014, second term since 2021)
- Dafra Pharma R&D, Tournhout, Belgium (2011-2013)